AngioDynamics Inc ANGO
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if ANGO is a good fit for your portfolio.
News
-
AngioDynamics Shares Rise 10% After FDA Clears AlphaVac F18 System
-
AngioDynamics Gets FDA Clearance For Pulmonary Embolism Treatment
-
AngioDynamics Reports Fiscal Year 2024 Third Quarter Financial Results; Updates Fiscal Year 2024 Guidance to Reflect Asset Divestiture
-
AngioDynamics Receives 510(k) Clearance for AlphaVac F1885 System in Treatment of PE
-
AngioDynamics Settles Multi-Year Patent Dispute with Becton Dickinson & Co
-
AngioDynamics Announces Settlement of All Patent Litigation with C.R. Bard, Inc.
-
AngioDynamics to Report Fiscal 2024 Third Quarter Financial Results on April 4, 2024
-
AngioDynamics to Participate in a Fireside Chat at the Oppenheimer Virtual Healthcare MedTech & Services Conference
Trading Information
- Previous Close Price
- $5.79
- Day Range
- $5.79–5.93
- 52-Week Range
- $5.27–11.37
- Bid/Ask
- $5.83 / $5.84
- Market Cap
- $233.72 Mil
- Volume/Avg
- 235,309 / 534,415
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 0.72
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. It generates maximum revenue from Endovascular Therapies. Geographically, the company derives a majority of its revenue from the United States.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Stock Style Box
- Small Value
- Total Number of Employees
- 815
- Website
- https://www.angiodynamics.com
Comparables
Valuation
|
Metric
|
ANGO
|
MMSI
|
SIBN
|
|---|---|---|---|
Price/Earnings (Normalized) | — | 24.38 | — |
Price/Book Value | 1.09 | 3.53 | 3.66 |
Price/Sales | 0.72 | 3.41 | 4.22 |
Price/Cash Flow | — | 19.90 | — |
Price/Earnings
ANGO
MMSI
SIBN
Financial Strength
|
Metric
|
ANGO
|
MMSI
|
SIBN
|
|---|---|---|---|
Quick Ratio | 1.49 | 3.81 | 8.01 |
Current Ratio | 2.29 | 5.45 | 9.01 |
Interest Coverage | — | 8.07 | −13.52 |
Quick Ratio
ANGO
MMSI
SIBN
Profitability
|
Metric
|
ANGO
|
MMSI
|
SIBN
|
|---|---|---|---|
Return on Assets (Normalized) | −2.40% | 9.43% | −8.97% |
Return on Equity (Normalized) | −3.15% | 14.77% | −12.61% |
Return on Invested Capital (Normalized) | −2.98% | 11.47% | −11.78% |
Return on Assets
ANGO
MMSI
SIBN
Medical Instruments & Supplies Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ISRG
| Intuitive Surgical Inc | Bfysfjcl | Drb | $133.8 Bil | |
BDX
| Becton Dickinson & Co | Crxfwxl | Rnpctf | $67.6 Bil | |
ALC
| Alcon Inc | Wxqzwppf | Zcgmfm | $39.1 Bil | |
WST
| West Pharmaceutical Services Inc | Kngxkfqmg | Vlh | $28.6 Bil | |
CLPBY
| Coloplast A/S ADR | Tzhtbbkr | Cmpg | $27.9 Bil | |
RMD
| ResMed Inc | Cmpcrhqnv | Llshsx | $27.0 Bil | |
BAX
| Baxter International Inc | Ggxkvzpc | Qysypcx | $20.9 Bil | |
COO
| The Cooper Companies Inc | Hnspwnby | Yyfdmq | $17.9 Bil | |
HOLX
| Hologic Inc | Zbpngpg | Dybgpv | $17.8 Bil | |
TFX
| Teleflex Inc | Ndfns | Ffsn | $9.9 Bil |